This Week at FDA: Drug voucher program hits a snag, GOP targets abortion drug, and more

This Week at FDA

This Week at FDAFerdous Al-Faruque

Biologics/ biosimilars/ vaccinesGovernment/legislationLeadershipMedical DevicesPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)